Carisma Therapeutics Statistics
Total Valuation
CARM has a market cap or net worth of $7.96 million. The enterprise value is $2.55 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CARM has 41.79 million shares outstanding. The number of shares has increased by 2.72% in one year.
| Current Share Class | 41.79M |
| Shares Outstanding | 41.79M |
| Shares Change (YoY) | +2.72% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 11.99% |
| Owned by Institutions (%) | 22.28% |
| Float | 31.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.40 |
| Forward PS | 0.60 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.34
| Current Ratio | 1.34 |
| Quick Ratio | 0.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -69.64% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -908.15% |
| Revenue Per Employee | $434,000 |
| Profits Per Employee | -$1.10M |
| Employee Count | 46 |
| Asset Turnover | 0.44 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.22% in the last 52 weeks. The beta is 2.94, so CARM's price volatility has been higher than the market average.
| Beta (5Y) | 2.94 |
| 52-Week Price Change | -85.22% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 44.80 |
| Average Volume (20 Days) | 956,496 |
Short Selling Information
The latest short interest is 841,044, so 2.01% of the outstanding shares have been sold short.
| Short Interest | 841,044 |
| Short Previous Month | 290,775 |
| Short % of Shares Out | 2.01% |
| Short % of Float | 2.69% |
| Short Ratio (days to cover) | 1.30 |
Income Statement
In the last 12 months, CARM had revenue of $19.96 million and -$50.77 million in losses. Loss per share was -$1.22.
| Revenue | 19.96M |
| Gross Profit | -39.71M |
| Operating Income | -50.00M |
| Pretax Income | -72.70M |
| Net Income | -50.77M |
| EBITDA | -47.68M |
| EBIT | -50.00M |
| Loss Per Share | -$1.22 |
Full Income StatementBalance Sheet
The company has $7.74 million in cash and $2.33 million in debt, giving a net cash position of $5.42 million or $0.13 per share.
| Cash & Cash Equivalents | 7.74M |
| Total Debt | 2.33M |
| Net Cash | 5.42M |
| Net Cash Per Share | $0.13 |
| Equity (Book Value) | -36.66M |
| Book Value Per Share | -0.88 |
| Working Capital | 3.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$47.56 million and capital expenditures -$106,000, giving a free cash flow of -$47.67 million.
| Operating Cash Flow | -47.56M |
| Capital Expenditures | -106,000 |
| Free Cash Flow | -47.67M |
| FCF Per Share | -$1.14 |
Full Cash Flow StatementMargins
Gross margin is -198.90%, with operating and profit margins of -250.47% and -254.28%.
| Gross Margin | -198.90% |
| Operating Margin | -250.47% |
| Pretax Margin | -254.28% |
| Profit Margin | -254.28% |
| EBITDA Margin | -238.83% |
| EBIT Margin | -250.47% |
| FCF Margin | n/a |